These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1481585)

  • 21. Defective dopaminergic regulation of prolactin secretion in patients with hyperprolactinemia.
    Serri O; Beauregard H; Somma M; Comtois R; Jilwan N; Hardy J
    Clin Invest Med; 1988 Dec; 11(6):387-91. PubMed ID: 3229037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapeutic results in hyperprolactinemic sterility patients].
    Melzer H
    Zentralbl Gynakol; 1987; 109(8):517-20. PubMed ID: 3604494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hachimijiogan treatment is effective in the management of infertile women with hyperprolactinemia or bromocriptine-resistant hyperprolactinemia.
    Usuki S; Usuki Y
    Am J Chin Med; 1989; 17(3-4):225-41. PubMed ID: 2633624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bromocriptine for induction of ovulation in hyperprolactinemic amenorrhea.
    Nillius SJ
    Acta Eur Fertil; 1984; 15(2):83-91. PubMed ID: 6475464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The safety of bromocriptine in hyperprolactinaemic female infertility: a literature review.
    Weil C
    Curr Med Res Opin; 1986; 10(3):172-95. PubMed ID: 3525009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bromocryptine-cyclofenil associated therapy: an effective and safe mode of treatment of female normoprolactinemic infertility.
    Moggi G; Giampietro O; De Luca Brunori I
    Acta Eur Fertil; 1983; 14(5):319-25. PubMed ID: 6424373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Disorders of the hypothalamo-hypophyseal system as a cause of infertility in hyperprolactinemia].
    Stepanskaia NV; Ovsiannikova TV; Pshenichnikova TIa
    Acta Univ Palacki Olomuc Fac Med; 1991; 129():163-73. PubMed ID: 1837659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of prolactin on serum androgens in normoprolactinaemic women.
    Mudge TJ; Blight L; White GH; Judd SJ
    Clin Reprod Fertil; 1983 Mar; 2(1):19-25. PubMed ID: 6227379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variations in prolactin secretion in hyper- and normoprolactinaemia with or without galactorrhoea.
    Godo G; Koloszar S; Daru J; Falkay G; Sas M
    Acta Med Hung; 1989; 46(1):43-51. PubMed ID: 2771583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case].
    Pasinetti E; Schivardi MR; Falsetti L; Gastaldi A
    Minerva Ginecol; 1989 Mar; 41(3):157-60. PubMed ID: 2666885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of bromocriptine in unexplained infertility.
    McBain JC; Pepperell RJ
    Clin Reprod Fertil; 1982 Jun; 1(2):145-50. PubMed ID: 6764750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptine in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level.
    Parsanezhad ME; Alborzi S; Jahromi BN
    Int J Fertil Womens Med; 2002; 47(6):272-7. PubMed ID: 12570169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of prolactin in luteal inadequacy: treatment of hyperprolactinaemia with bromocriptine.
    Atasü T; Kösebay D; Aksu F
    Curr Med Res Opin; 1988; 11(1):56-63. PubMed ID: 3383612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of bromocriptine & cabergoline on fertility outcome of hyperprolactinemic infertile women undergoing intrauterine insemination.
    Motazedian S; Babakhani L; Fereshtehnejad SM; Mojthahedi K
    Indian J Med Res; 2010 May; 131():670-4. PubMed ID: 20516539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolactin secretion in myotonic dystrophy.
    Marinković Z; Prelevic G; Han R; Würzburger M; Todorovic S
    Exp Clin Endocrinol; 1990 Dec; 96(3):247-52. PubMed ID: 2128051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of a dopamine antagonist (metoclopramide) on the release of the adenohypophyseal hormones in amenorrhoeic patients with and without hyperprolactinaemia.
    Seki K; Uesato T; Kato K
    Acta Endocrinol (Copenh); 1982 Oct; 101(2):166-70. PubMed ID: 6814135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovulation induction with bromocriptine in normoprolactinemic anovulatory women.
    Suginami H; Hamada K; Yano K; Kuroda G; Matsuura S
    J Clin Endocrinol Metab; 1986 May; 62(5):899-903. PubMed ID: 3958126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prolactin, bromocriptine and gonadal function in women: recent advances. II. Treatment of female hyperprolactinemia and other indications for the use of bromocriptine].
    Buvat J; Buvat-Herbaut M
    J Gynecol Obstet Biol Reprod (Paris); 1982; 11(4):509-21. PubMed ID: 6754799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decrease in serum prolactin during bromocriptine-induced pregnancy and subsequent restoration of reproductive function in some hyperprolactinemic women.
    Seki K; Kato K
    Endocrinol Jpn; 1987 Oct; 34(5):701-7. PubMed ID: 3436300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.